Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Adiponectin in chronic heart failure: influence of diabetes and genetic variants

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A totally new system is needed for drug research and development

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Patients not patents: Drug research and development as a public enterprise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prediction of coronary heart disease or heart failure using high-sensitivity cardiac troponin T: a pilot study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Familial hypercholesterolaemia: cholesterol efflux and coronary disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Diabetes i familien – familien og diabetes

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  2. Diabetespatienter er afhængige af et løft af det nære sundhedsvæsen

    Publikation: AndetUdgivelser på nettet - Net-publikationFormidling

  3. Forord

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  4. Kun gode relationer kan nedbryde ’Sundhedsvæsnets Bermudatrekant’

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  • Serge Masson
  • Francesca Gori
  • Roberto Latini
  • Valentina Milani
  • Allan Flyvbjerg
  • Jan Frystyk
  • Luisa Crociati
  • Silvia Pietri
  • Tarcisio Vago
  • Simona Barlera
  • Aldo P Maggioni
  • Gianni Tognoni
  • Luigi Tavazzi
  • Torbjørn Omland
  • Maria Grazia Franzosi
  • GISSI-HF Investigators
Vis graf over relationer

BACKGROUND: We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin.

METHODS: Plasma adiponectin was measured at entry and after 3 months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D.

RESULTS: Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95%CI] per 1 SD increase in adiponectin concentration = 1·24[1·12-1·37], P < 0·0001) and improved prognostic discrimination beyond clinical risk factors (integrated discrimination improvement, P = 0·005). Patients with increasing adiponectin concentration over 3 months had worse outcome than those with stable levels (unadjusted HR = 1·46[1·09-1·96], P = 0·01); this relation was attenuated by the genetic variants examined and by robust confounders like age, diabetes, BMI or NT-proBNP (adjusted HR = 1·37[0·97-1·94], P = 0·075).

CONCLUSIONS: Although diabetes and genetic variants at the ADIPOQ gene influence the circulating levels of adiponectin in CHF, higher plasma adipokine levels, but not genetic variants, are consistently associated with a poor prognosis.

TidsskriftEuropean Journal of Clinical Investigation
Udgave nummer12
Sider (fra-til)1330-8
Antal sider9
StatusUdgivet - dec. 2011
Eksternt udgivetJa

ID: 51725351